# Latent Labs

Source: https://onco.cc/companies/latent-labs/  
OnCo record `latent-labs` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Founded by an AlphaFold co-developer to make protein design programmable; released Latent-X in 2025.

## Summary

Latent Labs, based in London, was founded by an AlphaFold co-developer to make protein design programmable, and released Latent-X in 2025. Latent-X generates de novo binders, including macrocycles and mini-binders, with reported high wet-lab hit rates, and is available through a web platform. OnCo links it to de novo designed protein binders. Whether designed macrocycles and mini-binders can reach intracellular cancer targets that antibodies cannot is the open question. The de novo protein binder page carries the wider field.

## Fields

- Kind: Company
- Last checked: 2026-09-08
- Tags: ai; protein-design
- HQ: London
- Type: ai-software
- Website: https://www.latentlabs.com

## Sources

- Official website: https://www.latentlabs.com

## Connected records

- fronts: [Drug Discovery Platforms](https://onco.cc/fronts/drug-discovery/)
- technologies: [AI-driven drug & target discovery](https://onco.cc/technologies/ai-drug-design/), [De novo designed protein binders](https://onco.cc/technologies/de-novo-protein-design/)

---
JSON: https://onco.cc/api/v1/entities/latent-labs.json